This is a working overview of immunomodulator, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-11-08. Anything still debated is marked as such rather than presented as settled.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Clinical interest has centered on chronic viral hepatitis, on immune restoration in various conditions, and on use as an adjuvant intended to improve responses to vaccines. Trials have reported mixed results, and regulatory status differs sharply between countries; in some places it is a prescription product, while elsewhere it is sold without an approved therapeutic indication. Because published studies vary widely in design, population, and endpoints, comparisons across them are difficult and no single conclusion covers the whole literature.
Thymosin alpha 1 is a short peptide of 28 amino acid residues that derives from the amino terminal region of a larger precursor protein known as prothymosin alpha. The peptide carries an acetyl group on its first residue and contains no disulfide bonds or carbohydrate chains. Its sequence is highly conserved across mammalian species, which is one reason laboratories treat it as a molecule with a defined and reproducible structure rather than a variable tissue extract. The name follows an early naming convention for thymus-derived fractions and does not imply that the peptide acts as a hormone in the classical endocrine sense.
Biologically, the peptide is studied mainly in the context of immune cell development and regulation. It is produced in the thymus and in several other tissues, and it appears to influence the maturation and activity of T cells and other immune populations. Laboratory work describes effects on cytokine production, on the balance between T cell subsets, and on the function of dendritic cells. Much of this evidence comes from cell culture and animal models, so the extent to which the same pathways operate in humans remains an open question.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
Within the immune system, the peptide acts on several cell types rather than a single target. Reported activities include promotion of T-cell maturation, enhancement of natural killer cell activity, and modulation of cytokine production by dendritic cells and macrophages. Some of these effects appear to operate through toll-like receptor signaling, though the precise receptor-level mechanism remains debated. Whether the observed immune changes translate into clinical benefit is a separate question and depends on the indication studied.
The peptide was described in the 1970s as a component of thymic extracts, and early research focused on restoring immune function in immunodeficiency states. A synthetic version entered clinical development in the 1980s and is approved as a drug in several countries for conditions such as chronic hepatitis B and certain immunodeficiencies. Approval status varies widely by jurisdiction, and in the United States it is not an approved therapeutic. Regulatory and clinical positions differ, so statements about efficacy should be tied to specific indications and studies.
The peptide is generated in cells by cleavage of prothymosin alpha, a larger acidic protein encoded by the PTMA gene. Prothymosin alpha is expressed in many tissues, not only in the thymus, and its functions include nuclear roles in chromatin-related processes. The 28-residue fragment corresponds to the N-terminal portion of that precursor. How the cleavage occurs and how the fragment's concentration is regulated remain open questions; circulating amounts are small and difficult to measure reliably with routine assays.
Thymosin alpha 1 is a short peptide first isolated from bovine thymus tissue in the early 1970s during fractionation work aimed at identifying factors that influence T cell development. It belongs to a family of acidic thymic peptides, and the original preparations contained several components that were later separated by chromatography. The compound is now produced synthetically rather than extracted from tissue, which removes batch variability tied to animal sourcing. Researchers describe it as an immunomodulatory peptide because laboratory studies show effects on several cell types of the innate and adaptive immune systems.
In vitro (meaning in glass, or in the glass) studies are performed with cells or biological molecules outside their normal biological context. Colloquially called "test-tube experiments", these studies in biology and its subdisciplines are traditionally done in labware such as test tubes, flasks, Petri dishes, and microtiter plates. Studies conducted using components of an organism that have been isolated from their usual biological surroundings permit a more detailed or more convenient analysis than can be done with whole organisms; however, results obtained from in vitro experiments may not fully or accurately predict the effects on a whole organism. In contrast to in vitro experiments, in vivo studies are those conducted in living organisms, including humans, known as clinical trials, and whole plants.
== Research == A 2016 review found that reserpine reduced systolic blood pressure (SBP) by about 8 mmHg compared to placebo, and may be as effective at reducing SBP as other front-line hypertensive drugs, although more research is needed to determine a dose-specific safety profile.
=== Polling === In October, before the strikes, a poll by AtlasIntel showed that approximately 64% of Venezuelans abroad support US military intervention to depose Maduro, compared with 34% within Venezuela. In December, a poll by Datanalisis found that 55% of Venezuelans opposed foreign military intervention while 23% supported it. After the strikes, a poll by Reuters surveying 1,248 adults in the United States found that 33% of Americans approved of the military action, while 34% did not; 65% of Republicans supported the action compared to 11% of Democrats, and 72% of Americans were concerned that the US would get too involved in Venezuela, including 54% of Republicans. The same poll showed that Trump approval ratings rose to 42% after the attack, the highest rating since October 2025, when his approval rating was 39%. A poll was made by The Economist on 9 January, surveying 600 Venezuelan residents of different ages and sex to reflect the national population. Most respondents were positive about the intervention, only 13% of respondents mildly opposed the capture of Maduro. The 18% of respondents oppose United States governance in Venezuela. Most respondents want a quick change of government, with 43% supporting María Corina Machado as the leader and 13% supporting Delcy Rodríguez. The 91% of respondents answering in support for a change of government within a year.
The nitrogen rule states that organic compounds containing exclusively hydrogen, carbon, nitrogen, oxygen, silicon, phosphorus, sulfur, and the halogens either have (1) an odd nominal mass that indicates an odd number of nitrogen atoms are present or (2) an even nominal mass that indicates an even number of nitrogen atoms in the molecular formula of the neutral compound. The nitrogen rule is not a rule as much as a general principle which may prove useful when attempting to solve organic mass spectrometry structures.
=== Before 2021 === The Independent in 2008 described the Russo-Georgian War as "reviv[ing] the spectre of the most tense days of the Cold War" and described it as the beginning of a "new Cold War". In a 2016 op-ed for The Straits Times, Kor Kian Beng wrote that the phrase "new Cold War" between US-led allies versus Beijing and Moscow did not gain traction in China at first when it first emerged in 2014. He says this changed in 2016 after the United States announced its plan to deploy Terminal High Altitude Area Defense (THAAD) in South Korea against North Korea, but China and Russia found the advanced anti-missile system too close for comfort. The US also supported a tribunal ruling against China in favor of the Philippines in the South China Sea. Afterwards, he wrote, the term "new Cold War" appeared in Chinese media more often. In a June 2019 interview with a college magazine, University of Southern California (USC) professors Steven Lamy and Robert D. English agreed that talk of a "new Cold War" was intended to distract political publics from bigger issues such as globalisation, global warming, global poverty and increasing inequality. Lamy said there was no new Cold War ("although it serves a purpose for some people to suggest that, especially those who want to increase military budgets") but instead described the heightened global tension as a period of great power rivalry between the US, China and Russia.
Sources: en.wikipedia.org
Seth helps a very drunk Amber through her breakup with her fiancé, Ryan. It is shown that Seth is finally able to support himself with a job and house. He and Sarah chat later on about how he's doing over the phone. Seth sends Amber a baby crib to assemble once he discovers that she is pregnant.
==== Immunoturbidimetry ==== Immunoturbidimetry uses antibodies specific to a substance of interest to cause a measurable change in turbidity (cloudiness) of a solution. An example protocol for HbA1c measurement by immunoturbidimetry is:
Spray ionization methods involve the formation of aerosol particles from a liquid solution and the formation of bare ions after solvent evaporation. Solvent-assisted ionization (SAI) is a method in which charged droplets are produced by introducing a solution containing analyte into a heated inlet tube of an atmospheric pressure ionization mass spectrometer. Just as in Electrospray Ionization (ESI), desolvation of the charged droplets produces multiply charged analyte ions. Volatile and nonvolatile compounds are analyzed by SAI, and high voltage is not required to achieve sensitivity comparable to ESI. Application of a voltage to the solution entering the hot inlet through a zero dead volume fitting connected to fused silica tubing produces ESI-like mass spectra, but with higher sensitivity. The inlet tube to the mass spectrometer becomes the ion source.
Commission B1: Thermodynamics and Transfer Processes The objectives of Commission B1 on Thermodynamics and Transfer Processes are to provide academic and industrial information and data, and to propose any solutions on thermodynamics and transfer processes. The Commission B1 has been extremely active in IIR Working Groups, sub-commissions, IIR conferences, co-sponsored conferences, and commission business meetings. As well as being involved in IIR Working Groups on the mitigation of direct emissions of greenhouse gases in refrigeration, the commission is equally involved in the Working Group on Life Cycle Climate Performance (LCCP) Evaluation. Active in IIR conferences and congresses, Commission B1 similarly organises workshops in various fields such as refrigerant charge reduction in refrigerating systems. Initiatives and opportunities, such as the phase-down of high-GWP refrigerants, energy-efficient buildings and cars, transport refrigeration, food preservation, the economic importance of the refrigeration sector, the involvement of the younger generation and identifying industrial needs are all at the heart of Commission B1.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
The name reflects an early convention for naming thymus-derived fractions. The peptide is characterized and measured as a defined molecule, and it does not operate through a single classical endocrine axis.